Abstract:Engineering inorganic nanoparticles with a biocompatible shell to improve their physicochemical properties is a vital step in taking advantage of their superior magnetic, optical, and photothermal properties as multifunctional molecular imaging probes for disease diagnosis and treatment. The grafting/peeling-off strategy we developed for nanoparticle surface coating can fully control the targeting capability of functional nanoprobes by changing their colloidal behaviors such as diffusion and sedimentation rates at the desired sites. We demonstrated that a cleavable coating layer initially immobilized on the surface of magnetic resonance imaging probes not only makes the nanoparticles water-soluble but also can be selectively removed by specific enzymes, thereby resulting in a significant decrease of their water solubility in an enzyme-rich environment. Upon removal of surface coating, the changes in hydrodynamic size and surface charges of nanoprobes as a result of interacting with biomolecules and proteins lead to dramatic changes in their in vivo colloidal behaviors ( i. e., slow diffusion rates, tendency to aggregate and precipitate), which were quantitatively evaluated by examining changes in their hydrodynamic sizes, magnetic properties, and count rates during the size measurement. Because the retention time of nanoprobes within the tumor tissues depends on the uptake and excretion rate of the nanoprobes through the tumors, selective activation of nanoprobes by a specific enzyme resulted in much higher tumor accumulation and longer retention time within the tumors than that of the inactive nanoprobes, which passively passed through the tumors. The imaging contrast effect of tumors using activatable nanoprobes was significantly improved over using inactive probes. Therefore, the grafting/peeling-off strategy, as a general design approach for surface modification of nanoprobes, offers a promising and highly efficient way to render the nanoparticles suitable for targeted imaging of tumors.

Enzymatically Controlled Nanoflares for Specific Molecular Recognition and Biosensing

Covalent Amide-Bonded Nanoflares For High-Fidelity Intracellular Sensing And Targeted Therapy: A Superstable Nanosystem Free Of Nonspecific Interferences

Controlled Nano-Bio Interface of Functional Nanoprobes for in Vivo Monitoring Enzyme Activity in Tumors.

An Aptamer-Tethered, DNAzyme-embedded Molecular Beacon for Simultaneous Detection and Regulation of Tumor-Related Genes in Living Cells.

A Versatile Activatable Fluorescence Probing Platform for Cancer Cells in Vitro and in Vivo Based on Self-Assembled Aptamer/carbon Nanotube Ensembles.

Engineering of switchable aptamer micelle flares for molecular imaging in living cells.

Design and Engineering of Hypoxia and Acidic pH Dual‐Stimuli‐Responsive Intelligent Fluorescent Nanoprobe for Precise Tumor Imaging

A Molecular Design Strategy Toward Enzyme-Activated Probes with Near-Infrared I and II Fluorescence for Targeted Cancer Imaging

DNA-enabled rational design of fluorescence-Raman bimodal nanoprobes for cancer imaging and therapy

Recent Advances in the Enzyme-Activatable Organic Fluorescent Probes for Tumor Imaging and Therapy

A Smart Intracellular Self-Assembling Bioorthogonal Raman Active Nanoprobe for Targeted Tumor Imaging

Aptamer-based fluorescent sensors for the detection of cancer biomarkers.

Activatable Nanoprobe with Aggregation-Induced Dual Fluorescence and Photoacoustic Signal Enhancement for Tumor Precision Imaging and Radiotherapy.

Nanoflares as probes for cancer diagnostics.

Precision Spherical Nucleic Acids Enable Sensitive Fen1 Imaging And Controllable Drug Delivery For Cancer-Specific Therapy

An Efficient Strategy for Constructing Fluorescent Nanoprobes for Prolonged and Accurate Tumor Imaging.

Engineering Logic DNA Nanoprobes on Live Cell Membranes for Simultaneously Monitoring Extracellular pH and Precise Drug Delivery

Surface-engineered quantum dots/electrospun nanofibers as a networked fluorescence aptasensing platform toward biomarkers.

Dual Factor Coactivatable Fluorescent Nanosensor with Boosted Cytoplasmic Biomarker Accessibility Toward Selective Tumor Imaging

A NanoFlare-Based Strategy for in Situ Tumor Margin Demarcation and Neoadjuvant Gene/Photothermal Therapy.

Site-Specific Cascade-Activatable Fluorogenic Nanomicelles Enable Precision and Accuracy Imaging of Pulmonary Metastatic Tumor